These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23611568)

  • 1. Population pharmacokinetic study of cyclosporine in the hematopoietic stem cell transplant recipients.
    Zhou Y; Sheng XY; Xu JY; Bi SS; Lu W; Cui YM
    Int J Clin Pharmacol Ther; 2013 Jul; 51(7):568-75. PubMed ID: 23611568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetic study of cyclosporine based on NONMEM in Chinese liver transplant recipients.
    Sun B; Li XY; Gao JW; Rui JZ; Guo YK; Peng ZH; Liu GL
    Ther Drug Monit; 2010 Dec; 32(6):715-22. PubMed ID: 21068646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posttransplant day significantly influences pharmacokinetics of cyclosporine after hematopoietic stem cell transplantation.
    Jacobson PA; Ng J; Green KG; Rogosheske J; Brundage R
    Biol Blood Marrow Transplant; 2003 May; 9(5):304-11. PubMed ID: 12766880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy.
    Wilhelm AJ; de Graaf P; Veldkamp AI; Janssen JJ; Huijgens PC; Swart EL
    Br J Clin Pharmacol; 2012 Apr; 73(4):553-63. PubMed ID: 21988410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of cyclosporine in Chinese children receiving hematopoietic stem cell transplantation.
    Li TF; Hu L; Ma XL; Huang L; Liu XM; Luo XX; Feng WY; Wu CF
    Acta Pharmacol Sin; 2019 Dec; 40(12):1603-1610. PubMed ID: 31341257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population Pharmacokinetic Modeling of Cyclosporine Among Malaysian Renal Transplant Patients: An Evaluation of Methods to Handle Missing Doses in Conventional Drug-Monitoring Data.
    Albitar O; Ballouze R; Harun SN; Mohamed Noor DA; Sheikh Ghadzi SM
    J Clin Pharmacol; 2020 Nov; 60(11):1474-1482. PubMed ID: 32557653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic monitoring of intravenous cyclosporine A in pediatric stem-cell transplant recipients. The trough level is not enough.
    Schrauder A; Saleh S; Sykora KW; Hoy H; Welte K; Boos J; Hempel G; Grigull L
    Pediatr Transplant; 2009 Jun; 13(4):444-50. PubMed ID: 18482216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Converting cyclosporine A from intravenous to oral administration in hematopoietic stem cell transplant recipients and the role of azole antifungals.
    Atiq F; Hameli E; Broers AEC; Doorduijn JK; Van Gelder T; Andrews LM; Koch BCP; Versmissen J; de Winter BCM
    Eur J Clin Pharmacol; 2018 Jun; 74(6):767-773. PubMed ID: 29500599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics of ciclosporin in allogeneic hematopoietic stem cell transplant recipients: C-reactive protein as a novel covariate for clearance.
    Ling J; Yang XP; Dong LL; Jiang Y; Zou SL; Hu N; Chen R
    J Clin Pharm Ther; 2022 Apr; 47(4):483-492. PubMed ID: 34779003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited sampling strategies for estimating intravenous and oral cyclosporine area under the curve in pediatric hematopoietic stem cell transplantation.
    Sarem S; Nekka F; Barrière O; Bittencourt H; Duval M; Teira P; Haddad E; Théorêt Y; Lapeyraque AL; Litalien C
    Ther Drug Monit; 2015 Apr; 37(2):198-205. PubMed ID: 25162214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A population pharmacokinetic model of ciclosporin applicable for assisting dose management of kidney transplant recipients.
    Falck P; Midtvedt K; Vân Lê TT; Storehagen L; Holdaas H; Hartmann A; Asberg A
    Clin Pharmacokinet; 2009; 48(9):615-23. PubMed ID: 19725595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics of cyclosporine in hematopoietic stem cell transplant patients: consideration of genetic polymorphisms.
    Kim MG; Kim IW; Choi B; Han N; Yun HY; Park S; Oh JM
    Ann Pharmacother; 2015 Jun; 49(6):622-30. PubMed ID: 25818517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NONMEM population pharmacokinetic modeling of orally administered cyclosporine from routine drug monitoring data after heart transplantation.
    Parke J; Charles BG
    Ther Drug Monit; 1998 Jun; 20(3):284-93. PubMed ID: 9631925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics and bayesian estimator of cyclosporine in pediatric renal transplant patients.
    Irtan S; Saint-Marcoux F; Rousseau A; Zhang D; Leroy V; Marquet P; Jacqz-Aigrain E
    Ther Drug Monit; 2007 Feb; 29(1):96-102. PubMed ID: 17304156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of cyclosporine A based on NONMEM in Chinese allogeneic hematopoietic stem cell transplantation recipients.
    Zhou H; Gao Y; Cheng XL; Li ZD
    Eur J Drug Metab Pharmacokinet; 2012 Dec; 37(4):271-8. PubMed ID: 22446981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of area under the whole blood concentration versus time curve after first intravenous cyclosporine dose in children undergoing hematopoietic stem cell transplant: limited sampling strategies.
    Sibbald C; Seto W; Taylor T; Saunders EF; Doyle J; Dupuis LL
    Ther Drug Monit; 2008 Aug; 30(4):434-8. PubMed ID: 18641547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics and Bayesian estimation of cyclosporine in a Tunisian population of hematopoietic stem cell transplant recipient.
    Eljebari H; Gaies E; Fradj NB; Jebabli N; Salouage I; Trabelsi S; Lakhal M; Klouz A
    Eur J Clin Pharmacol; 2012 Nov; 68(11):1517-24. PubMed ID: 22527344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Population pharmacokinetic study of tacrolimus in patients with hematopoietic stem cell transplant].
    Xue L; Rui JZ; Zhang Y; Miao LY
    Yao Xue Xue Bao; 2009 Oct; 44(10):1145-51. PubMed ID: 20055140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Achieving adequate cyclosporine exposure in liver transplant recipients: a novel strategy for monitoring and dosing using intravenous therapy.
    Lück R; Böger J; Kuse E; Klempnauer J; Nashan B
    Liver Transpl; 2004 May; 10(5):686-91. PubMed ID: 15108262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of cyclosporine in chinese cardiac transplant recipients.
    Yin OQ; Lau SK; Chow MS
    Pharmacotherapy; 2006 Jun; 26(6):790-7. PubMed ID: 16716132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.